Last reviewed · How we verify
NCT07547878
Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
Not yet recruiting
Phase 4
What this trial tests
Phase 4 trial testing Finerenone in Chronic Kidney Disease in 64 participants. Not yet recruiting.
Timeline
30 April 2026
31 March 2029
Quick facts
| Lead sponsor | Baylor Research Institute |
|---|---|
| Phase | Phase 4 |
| Status | Not yet recruiting |
| Enrollment | 64 |
| Start date | 30 April 2026 |
| Estimated completion | 31 March 2029 |
Drugs / interventions tested
- Finerenone
- Semaglutide
- Lotensin
- Capoten
- Enalapril
- Monopril
- Lisinopril
- Univasc
- Aceon (PERINDOPRIL ARGININE) — full drug profile →
- Accupril (QUINAPRIL) — full drug profile →
- Altace
- Mavik
- Edarbi
- Atacand
- Avapro (IRBESARTAN HYDROCHLORIDE) — full drug profile →
- Cozaar
- Benicar
- Micardis
- Diovan
- Invokana (CANAGLIFLOZIN) — full drug profile →
- Farxiga (DAPAGLIFLOZIN) — full drug profile →
- Jardiance
- Ertugliflozin
- Brenzavvy
- Sotagliflozin
Conditions studied
- Chronic Kidney Disease — all drugs for Chronic Kidney Disease →
- Type 2 Diabetes — all drugs for Type 2 Diabetes →
Sponsor
Baylor Research Institute
Who can join
Eligibility, any sex, with Chronic Kidney Disease or Type 2 Diabetes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07547878
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Finerenone
Trials testing the same drug.
- NCT07351864 — Finerenone Plus SGLT2 Inhibitors in Heart Failure · Phase 4 · not yet recruiting
- NCT07326631 — Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure · NA · not yet recruiting
- NCT07235891 — Retinal Protective Effects of Novel Finerenone in Patients With Chronic Kidney Disease · Phase 4 · not yet recruiting
- NCT07056595 — Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial · NA · recruiting
- NCT06835322 — Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis · Phase 2 · recruiting
Other recruiting trials for Chronic Kidney Disease
Currently open trials in the same condition.
- NCT07469540 — Effects of an Aerobic Exercise Program on Cardiovascular Risk in Patients With Chronic Kidney Disease or Rheumatoid Arth · NA · recruiting
- NCT07169422 — Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care · NA · recruiting
- NCT07481526 — A Prospecitve Multicenter, Observational Registry Study · recruiting
- NCT07450820 — OPTIMISE-CKD Study_Dapagliflozin Effectiveness in CKD · recruiting
- NCT07107945 — A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease · Phase 3 · recruiting
Other Baylor Research Institute trials
Trials by the same sponsor.
- NCT07467720 — Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial · NA · not yet recruiting
- NCT07460583 — ProActive Athlete Heart Program: Proposal for Cardiac Risk Screening in Former High-Intensity Athletes · NA · not yet recruiting
- NCT07096544 — CALM Study: Cardiomems Assisted Lvad Management · NA · not yet recruiting
- NCT07220395 — eHealth Literacy Intervention for Spanish Speaking Older Adults in the US · NA · not yet recruiting
- NCT07518238 — Hernia Abd Wall Recons - BDE vs Exparel · Phase 2 · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
Data sources for this page
- Trial protocol + status: ClinicalTrials.gov NCT07547878 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Baylor Research Institute
- Last refreshed: recently
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07547878.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing